Director at HCA Healthcare (NYSE: HCA) granted 509 RSUs

Rhea-AI Filing Summary

DEPARLE NANCY ANN reported acquisition or exercise transactions in this Form 4 filing.

HCA Healthcare, Inc. director Nancy Ann DeParle reported receiving an equity award of 509 shares of common stock in the form of restricted share units, granted at a price of $0.00 per share as compensation rather than an open-market purchase. According to the footnote, these 509 restricted share units vest on the earlier of the company’s 2027 annual shareholders’ meeting or the first anniversary of the grant date. Following this award, DeParle directly holds a total of 21,910 shares of HCA Healthcare common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DEPARLE NANCY ANN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	509	$0.00	--

Holdings After Transaction: Common Stock — 21,910 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted share units granted: 509 shares Grant price per share: $0.00 per share Total shares after transaction: 21,910 shares +1 more

4 metrics

Restricted share units granted 509 shares Annual director equity award of common stock

Grant price per share $0.00 per share Equity compensation award, not open-market purchase

Total shares after transaction 21,910 shares Direct holdings of HCA common stock following award

Vesting condition 2027 meeting or 1-year from grant RSUs vest at earlier of 2027 annual shareholders’ meeting or first anniversary

Key Terms

restricted share units, annual director equity award, annual shareholders' meeting, grant date

4 terms

restricted share units financial

"Represents common stock underlying 509 restricted share units attributable to an annual director equity award"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

annual director equity award financial

"509 restricted share units attributable to an annual director equity award, which shall vest"

annual shareholders' meeting financial

"shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting"

grant date financial

"or the first anniversary of the grant date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEPARLE NANCY ANN

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		A(1)		509	A	$0	21,910	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.

	/s/ Kevin A. Ball, Attorney-in-Fact	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did HCA (HCA) director Nancy Ann DeParle report in this Form 4?

Nancy Ann DeParle reported receiving 509 HCA common shares via a restricted share unit award. The grant is compensation, not an open-market purchase, and increases her direct holdings to 21,910 shares of HCA common stock after the transaction.

How many HCA Healthcare (HCA) shares did the director acquire and at what price?

The director acquired 509 HCA common shares through a restricted share unit grant at $0.00 per share. This reflects an equity compensation award, meaning the shares were granted by the company rather than bought in the open market at a prevailing stock price.

When do the 509 restricted share units for HCA (HCA) vest?

The 509 restricted share units vest on the earlier of HCA’s 2027 annual shareholders’ meeting or the first anniversary of the grant date. Vesting means the director’s right to receive the underlying common shares becomes non-forfeitable at that time.

How many HCA Healthcare (HCA) shares does Nancy Ann DeParle own after this grant?

After the reported award, Nancy Ann DeParle directly holds 21,910 shares of HCA common stock. This figure includes the effect of the 509-share restricted unit grant disclosed, providing a snapshot of her total direct equity stake following the transaction.

Is this HCA (HCA) Form 4 transaction a buy or a compensation award?

This Form 4 shows a compensation award, not a market buy. The 509 shares were granted as restricted share units with a $0.00 grant price, reflecting standard director equity compensation rather than a discretionary purchase on the open market.